Looking at the micro data, we have an uptrend where we're following along the rising bottom. Looking a bit further out, we can see we're in a bullish wedge.
General trends say that this will come up, and the company will have only good news about their trials progressing which will drive the price higher.
Very near to $2 by the end of February, and we could very well see $4 by the end of Summer.